Silexion TherapeuticsSLXN
13F holders, Q1 2026 (March 31)7holders +1
1new positions
0sold out
1famous investor
$1.28avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding Silexion Therapeutics Corp. (SLXN) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($27K), Two Sigma Securities, LLC ($15K) and Montag A & Associates Inc. ($4K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Silexion Therapeutics Corp.
- CUSIP
- G1281K130
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $15K |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 20,378 shares bought and 2,214 shares sold, net +18,164 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Citadel Advisors | 0.00% | Add +71.5% | 20,926 | $27K |
| Two Sigma Securities, LLC | 0.00% | New | 11,657 | $15K |
| Montag A & Associates Inc. | 0.00% | No change | 3,000 | $4K |
| UBS Group AG | 0.00% | Reduce -69.4% | 517 | $662 |
| Pflug Koory, LLC | 0.00% | No change | 333 | $426 |
| Jones Financial Companies LLLP | 0.00% | No change | 26 | $32 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -98.1% | 20 | $26 |
"% of holder's portfolio" is SLXN's weight in each manager's 13F, not the share of Silexion Therapeutics Corp. the manager owns.